Concepedia

Jeffrey N. Miner

JN

Statistics

Publications

54

Citations

5K

H-Index

35

Active since

1989

Affiliations

Ligand Pharmaceuticals (United States)(Current)

AstraZeneca (United States)

University of California, San Francisco

Abbott (United States)

University of Otago

Jeffrey N. Miner is an author at Ligand Pharmaceuticals (United States) specializing in pharmacology, life sciences, and medicine.

ORCID

Publications per year

1989–2019

54

Publications

54

Transcription Factor Interactions: Selectors of Positive or Negative Regulation from a Single DNA Element

Marc I. Diamond, Jeffrey N. Miner, Steven K. Yoshinaga et al. · Science · 1990 · 1.3K citations

, , +17

Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids.

Enyu Imai, Jeffrey N. Miner, John A. Mitchell et al. · Journal of Biological Chemistry · 1993 · 307 citations · Full text

, , +15

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation

Annette Ives, Johji Nomura, Fabio Martinon et al. · Nature Communications · 2015 · 265 citations · Full text

, , +17

A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects

Michael J. Coghlan, Peer B. Jacobson, Ben Lane et al. · Molecular Endocrinology · 2003 · 221 citations

, , +17

The structural basis of androgen receptor activation: Intramolecular and intermolecular amino–carboxy interactions

Fred Schaufele, Xavier Carbonell, Martin Guerbadot et al. · Proceedings of the National Academy of Sciences · 2005 · 208 citations · Full text

, , +17

1–5 of 54